Related Experiment Video
Updated: May 27, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Cervical cancer screening: Less testing, smarter testing
Xian Wen Jin1, Andrea Sikon, Belinda Yen-Lieberman
1Department of Internal Medicine, G10, Cleveland Clinic, OH 44195, USA. jinx@ccf.org
Abstract:
In its 2009 recommendations for cervical cancer screening, the American College of Obstetricians and Gynecologists (ACOG) calls for less-frequent but smarter screening that integrates testing for human papillomavirus (HPV) infection with the Papanicolaou (Pap) test. We review the recommendations from this and other organizations and how and why they are evolving.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Preventive Healthcare Services
Cancer Prevention
Some...
Cancer Prevention
Some...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
